FdaApplication
ANDA 204382
Identifiers
- fda_app_no: ANDA204382
Properties
| Property | Value |
|---|---|
| applicant_name | AMNEAL PHARMACEUTICALS OF NEW YORK LLC |
| application_type | ANDA |
| approval_date | 2023-08-11 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| VALSARTAN AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE; VALSARTAN | 25MG;160MG | TABLET;ORAL |
| VALSARTAN AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE; VALSARTAN | 25MG;320MG | TABLET;ORAL |
| VALSARTAN AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE; VALSARTAN | 12.5MG;320MG | TABLET;ORAL |
| VALSARTAN AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE; VALSARTAN | 12.5MG;80MG | TABLET;ORAL |
| VALSARTAN AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE; VALSARTAN | 12.5MG;160MG | TABLET;ORAL |
5 products